Efficacy of Sitagliptin in Diabetes With High CVD RiskEfficacy of Sitagliptin in Diabetes With High CVD Risk
This study examines the benefits among type 2 diabetes patients at high risk for cardiovascular disease. Cardiovascular Diabetology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Health | Heart | Januvia | Study